GLIPATAB 10 mg contains Empagliflozin 10 mg. It is a sodium-glucose co-transporter-2 (SGLT2) inhibitor used to improve blood sugar control in adults with type 2 diabetes mellitus.
Uses:
-
Treatment of type 2 diabetes mellitus
-
Improves blood glucose control along with diet and exercise
-
Used alone or in combination with other antidiabetic medicines
-
Reduces the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease
Dose:
-
Adults: Usually 10 mg once daily in the morning or as directed by a physician.
-
Take the medicine exactly as prescribed by a healthcare professional.
-
Dose and duration depend on the patient's condition and response to treatment.
-
It may be taken with or without food. In patients tolerating the medicine, the dose may be increased to 25 mg once daily if needed.